1. Home
  2. NMM vs ALMR Comparison

NMM vs ALMR Comparison

Compare NMM & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navios Maritime Partners LP

NMM

Navios Maritime Partners LP

N/A

Current Price

$85.40

Market Cap

2.2B

ML Signal

N/A

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$31.69

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NMM
ALMR
Founded
2007
2018
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
NMM
ALMR
Price
$85.40
$31.69
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
★ $110.25
$37.00
AVG Volume (30 Days)
138.9K
★ 767.3K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 0.28%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.68
$64.80
Revenue Next Year
$5.27
$37.27
P/E Ratio
$7.24
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.76
$21.58
52 Week High
$97.00
$39.61

Technical Indicators

Market Signals
Indicator
NMM
ALMR
Relative Strength Index (RSI) 40.80 54.18
Support Level $69.21 $23.52
Resistance Level $92.02 $37.81
Average True Range (ATR) 2.64 2.60
MACD -0.47 -0.02
Stochastic Oscillator 32.40 63.67

Price Performance

Historical Comparison
NMM
ALMR

About NMM Navios Maritime Partners LP

Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: